Search clinical trials for: Exenatide extended release
Total 6568 results
-
Eisai Inc.CompletedSymptomatic Gastroesophageal Reflux Disease (sGERD)United States
-
UMC UtrechtCompletedAtopic DermatitisNetherlands
-
Novo Nordisk A/SBodyMediaCompletedDiabetes Type 2United States
-
Erasmus Medical CenterRecruitingGlioblastomaNetherlands
-
Lawson Health Research InstituteRecruitingTransient Ischemic Attack | Acute Ischemic Stroke | Intracardiac ThrombusCanada
-
Centre Antoine LacassagneCentre Méditerranéen de Médecine Moléculaire UMR_S-1065Terminated
-
Health Sciences North Research InstituteCompleted
-
Region SkaneCompletedDermatitis, Allergic ContactSweden
-
Brigham and Women's HospitalNational Institute on Drug Abuse (NIDA); Arthritis FoundationCompletedDepression | Anxiety | Degenerative Disc Disease | Chronic Low Back PainUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus
-
Georgetown UniversityTerminatedRenal Transplant RecipientsUnited States
-
University of Illinois at ChicagoAstellas Pharma US, Inc.CompletedKidney TransplantationUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure | Kidney DysfunctionUnited States
-
Chang Gung Memorial HospitalAstraZenecaCompletedPrimary Anxiety Disorders | Mood Disorders With Comorbid Anxiety SymptomsTaiwan
-
DepomedCompleted
-
Erasmus Medical CenterRecruiting
-
Stockholm South General HospitalCompletedCritical Illness | Physical DisabilitySweden
-
Ain Shams UniversityRecruiting
-
Astellas Pharma IncCompleted
-
Wake Forest UniversityCompleted
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
Astellas Pharma IncCompletedMajor Depressive Disorder PatientsJapan
-
IPCA Laboratories Ltd.Completed
-
AstraZenecaEli Lilly and CompanyTerminatedDiabetes MellitusUnited States, Canada
-
AstraZenecaEli Lilly and CompanyCompletedType 2 DiabetesBrazil, Mexico
-
University Health Network, TorontoEli Lilly and CompanyCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 DiabetesUnited States, Romania, Canada, Mexico, South Africa
-
Ironshore Pharmaceuticals and Development, IncCompletedAttention-Deficit Hyperactivity Disorder (ADHD)United States
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedConstipationUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary Bladder, OveractiveUnited States
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR)Completed
-
Merck Sharp & Dohme LLCTerminated
-
Seattle Children's HospitalWithdrawnInflammation | Septic Shock | Glucose Homeostasis | Organ Dysfunction | Health-related Quality of LifeUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Cliniques universitaires Saint-Luc- Université...CompletedType 2 Diabetes MellitusBelgium
-
Harvard University Faculty of MedicineNational Institute on Drug Abuse (NIDA)UnknownTobacco AddictionUnited States
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Amsterdam UMC, location VUmcCompletedType 2 Diabetes Mellitus | Congestive Heart FailureNetherlands
-
Carl T. Hayden VA Medical CenterAmerican Diabetes Association; Amylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
Astellas Pharma IncCompleted
-
Alcobra Ltd.CompletedFragile X SyndromeUnited States, Israel
-
AstraZenecaCompleted
-
Ewha Womans UniversityWithdrawnMajor Depressive DisorderKorea, Republic of
-
AstraZenecaCompleted
-
University of California, DavisEli Lilly and Company; Amylin Pharmaceuticals, LLC.TerminatedDiabetes Complications | Fatty LiverUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Romania, Canada, Mexico, South Africa